Click here to submit your feedback for the webinar. Haemophilia is an X-linked bleeding disorder. This is caused by a missing or defective VII factor, a clotting protein. People with the condition may bleed more severely or for a longer time following an injury. There are two main modes of therapy for haemophilia patients which are either to stop bleeding (on-demand) or to infuse clotting factors to prevent bleeds (prophylaxis). Outcomes of both these therapies may depend on several factors.
To gain more insights, please join the expert Dr. Vijaya Kumar who will be discussing “Haemophilia - On-Demand Treatment Vs Prophylaxis - What Fares Better In Restoring HRQoL”. Takeda and Docplexus have organized a webinar on 12th June 2020, Friday from 3.30 to 4.30 pm . Stay tuned!! VV-MTG-3690 Disclaimer The information contained herein is available to the public for information purposes only; it…
